Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in ESP Block for Radical Mastectomy
NCT05110339Completed
- Sponsor
- Universidad Autónoma de Tamaulipas
- Start
- Nov 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Universidad Autónoma de Tamaulipas. Primary endpoint: Postoperative Pain score at 24 hours. Started Nov 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05110339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05110339.